Lundbeck Initiates Clinical Trial Evaluating Clobazam for Dravet Syndrome
Go back to Lundbeck Initiates Clinical Trial Evaluating Clobazam for Dravet Syndrome| H Lundbeck A/S Sponsored ADR (AMEX: HLUYY) | Delayed: 22.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.00 | 52 Week High | $42.17 | |||
| Open | $14.78 | 52 Week Low | $29.71 | |||
| Day High | $22.00 | P/E | N/A | |||
| Day Low | $22.00 | EPS | $0.00 | |||
| Volume | 505,344 | |||||
| Healtheuniverse, Inc. (AMEX: LUN) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.00 | |||
| Open | $0.00 | 52 Week Low | $0.00 | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $0.00 | |||
| Volume | 0 | |||||
